74% Science-based targets status Submitted At Össur everyone is responsible for sustainability, and we are proud to have more than 4,000 employees around the world contributing to making a positive impact. We have ambitious goals and are committed to the well-being of our planet and future ...
From 2014 to 2023, the NMPA approved a total of 250 innovative medical devices manufactured by 167 domestic and 18 overseas enterprises, which means over a quarter were approved in 2023. This clearly demonstrates the increasing momentum for companies, both domestic and international, to go-to-mark...
On February 5, 2021, the NMPA (National Medical Products Administration) issued the 2020 Annual Report for Medical Device Registration. In 2020, the NMPA received a total of 10,579 applications for the initial registration, registration renewals and changes in licensing items of Class III (Domestic...
中国医学科学院年报 1980=Annual Report CHINESE ACADEMY OF MEDICAL SCIENCES中国医学科学院中国医学科学院年报 1980=Annual Report CHINESE ACADEMY OF MEDICAL SCIENCES中国医学科学院
https://www.medivir.com/investors/reports#FinancialReports2023 For additional information, please contact Magnus Christensen, CFO Telephone: +46 8 5468 3100 E-mail:magnus.christensen@medivir.com Medivir in brief Medivir develops innovative drugs with a focus on cancer where the unmet medical needs ar...
(HALEU, uranium enriched up to 19.75%) Enhanced Urenco Isotopes provision of enriched and depleted isotopes of elements other than uranium for medical, industrial and research applications Responsible nuclear stewardship, including nuclear materials management and decommissioning Revenue: €1,922.3 million ...
Information on the financial year 2023, our strategy and our targets can be found in the Fresenius Annual Report 2023.
爱德华兹生命科学I 2023年年度报告1当我回想起去年,以及有幸被任命为爱德华兹生命科学公司首席执行官时,一些难忘的时刻浮现在我的脑海中:与我们数千名员工一起参加在欧文举行的年度患者体验活动,我们从患者的治疗旅程中获得了宝贵的见解;与我们在亚洲、加勒比、欧洲和美国的出色员工共度时光;与爱尔兰的一位同事同台竞技...
Catalogue of Drugs for Basic National Medical Insurance/Employment Injury Insurance/Birth Insurance (2022) From January 1, 2023 to June 30, 2023 8 2023 Semi-Annual Report of Huadong Medicine Co., Ltd. Section II. Company Profile and Key Financial Indicators I. Company information Stock name (...
2023-24 INTEGRATED ANNUAL REPORT 2022-23 BRSR, GRI & ESG DATA BOOK 2022-23 ANNUAL REPORT 2021-22 ESG REPORT 2021-22 ANNUAL REPORT 2020-21 ESG SUMMARY REPORT 2020-21 ARCHIVES FY: From April 1 – March 31 Know more about us >> Biocon Malaysia ...